Healthcare Journal of Oregon: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Journal of Oregon.

Press releases published on July 23, 2026

28 minutes ago

As Employer Demand for Financial Wellness Benefits Accelerates, medZERO Expands Its Reach Across Industries

Indeterminate EIN Presswire

23 minutes ago

CRB Names Joe Finsterwald Chief Technology Officer

Indeterminate GlobeNewswire

27 minutes ago

Ardelyx to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

28 minutes ago

Collegium to Report Second Quarter 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

28 minutes ago

Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea

Indeterminate GlobeNewswire

28 minutes ago

Bone Biologics Issues Mid-Year Shareholder Update Highlighting Progress Across 2026 Priorities

Indeterminate GlobeNewswire

28 minutes ago

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

Indeterminate GlobeNewswire

28 minutes ago

Atsena Therapeutics Receives Orphan Designation from the European Medicines Agency (EMA) for ATSN-101 and ATSN-201

Indeterminate GlobeNewswire

28 minutes ago

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026

Indeterminate GlobeNewswire

28 minutes ago

Inhibikase Therapeutics Announces FDA Orphan Drug Designation Granted to IKT-001 for the Treatment of PAH

Indeterminate GlobeNewswire

28 minutes ago

PetMeds Announces Proposed Sale-Leaseback of Headquarters and Distribution Center Buildings for $37 Million

Indeterminate GlobeNewswire

28 minutes ago

iMDx GraftAssure Assay Guides Use of Potentially Kidney-Graft-Saving Drug in New Lancet Group Publication

Indeterminate GlobeNewswire

28 minutes ago

Curonix teams with AAOS to help address chronic pain with safer, patient-centered care solutions

Indeterminate GlobeNewswire

28 minutes ago

YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services

Indeterminate GlobeNewswire

an hour ago

Autonomix Medical Secures New U.S. Patent Strengthening Next-Generation Precision Neuromodulation Platform

Indeterminate GlobeNewswire

an hour ago

Revolver Brewing Becomes Revolver Beer and Spirits, Extending the Blood & Honey Brand into Whiskey, Gin and Vodka

Indeterminate GlobeNewswire

an hour ago

BioAdaptives Inc. Announces Operational Readiness and Completion of the Commercial Supply Chain for Upcoming Product Launches

Indeterminate GlobeNewswire

an hour ago

Ciprocopan (NXP100) Receives Marketing Approval in China for the Treatment of Patients with PNH Previously Untreated with Complement Inhibitors

Indeterminate GlobeNewswire

an hour ago

Healthcare Holding Schweiz sichert Syndikatsfinanzierung über CHF 80 Millionen

Indeterminate GlobeNewswire

an hour ago

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

Indeterminate GlobeNewswire